Clinical Trial Update: Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update describing safety assessments for two infusion schedules of SNS-595 in patients with hematologic malignancies. The report focuses …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• SNS-595

Snippet

Sponsor: Sunesis Pharmaceuticals | Conditions: Leukemia, Lymphocytic, Acute, Leukemia, Nonlymphocytic, Acute | Phase 1 | Status: COMPLETED